Senior Medical Science Liaison

Responsibilities

• Serve as the primary scientific and clinical resource for Opinion Leaders, Population Health Decision Makers, and healthcare providers in Northern California
• Execute medical and product strategies to advance the scientific platform for rare diseases, specifically Severe Active GPA/MPA and Sjogren’s Disease
• Conduct in-depth scientific exchanges to provide balanced clinical information consistent with compliance standards
• Engage with stakeholders within IDNs and other institutions to communicate clinical value, outcomes, and economic data
• Support Amgen-sponsored research, serve as a study lead, and liaise with potential investigators for non-sponsored research
• Provide field observations and insights to internal stakeholders to inform corporate strategies
• Lead congress activities, support speaker training, and mentor other MSLs as designated by leadership

Requirements

• Doctorate degree (e.g., Pharm.D., Ph.D., M.D., or D.O.)
• Or, a Master's degree with 3 years of Medical Affairs experience
• Or, a Bachelor's degree with 5 years of Medical Affairs experience
• Strong scientific communication and relationship management expertise

Preferred Qualifications

• Seven or more years in a medically related field, including clinical or medical research
• 2+ years of experience in a Medical Science Liaison role within the biotech or pharmaceutical industry
• Specific expertise in Rare Disease, GPA/MPA, or Sjogren’s Disease
• Previous experience managing the designated Northern California territory

Benefits

• Comprehensive health and welfare plans, including medical, dental, and vision coverage
• Retirement and Savings Plan with generous company contributions
• Discretionary annual bonus program and stock-based long-term incentives
• Award-winning time-off plans and flexible work models

About the Company

Amgen is a leading biotechnology company dedicated to serving patients living with serious illnesses. Since 1980, we have pioneered advancements in oncology, inflammation, general medicine, and rare diseases, leveraging human genetics and biologics manufacturing to deliver innovative medicines worldwide.